Abstract
Purpose
To investigate the relationship between physical function and quality of life in multiple myeloma patients.
Methods
In this retrospective cross-sectional study, data from patients with multiple myeloma (N = 63), who were referred to the department of Rehabilitation Medicine from October 2017 to May 2018, were reviewed. Patients were excluded based on the following criteria: acute illness, unstable medical conditions, impaired cognition or communication, refusal, or inability to perform the assessment. Physical function was evaluated with the Mini-Balance Evaluation Systems Test (Mini-BESTest), and the European Organization for Research and Treatment of Cancer questionnaires QLQ-C30 and QLQ-MY20 were used for the evaluation of quality of life. To evaluate fatigue and psychotic status, the Fatigue Severity Scale and Beck Depression Inventory were used. Patients were divided into two groups (“good-function group” and “poor-function group”), based on previously studied normative values of the Mini-BESTest. Clinical data was reviewed to interrogate the contributing factors of physical function.
Results
Positive correlations were observed between Mini-BESTest scores and all domains of the QLQ-C30. The Mini-BESTest score was lower in patients with lower serum hemoglobin (r = 0.396, p = 0.001) and albumin levels (r = 0.440, p < 0.001), severe disease-related symptoms (r = − 0.39, p = 0.02), and depression (r = − 0.538, p < 0.001). Further, the poor-function group showed lower hemoglobin (p = 0.024) and albumin levels (p = 0.004).
Conclusion
In patients with multiple myeloma, physical function had a significant relationship with quality of life. Low hemoglobin and albumin levels, severe disease- or treatment-related symptoms, and depression were related to decreased physical function, and thus consequentially exert an effect on quality of life in multiple myeloma patients.
Similar content being viewed by others
References
Sherman A, Simonton S, Latif U, Spohn R, Tricot G (2004) Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplant 33(9):955–962
Poulos AR, Gertz MA, Pankratz S, Post-White J (2001) Pain, mood disturbance, and quality of life in patients with multiple myeloma. Oncol Nurs Forum 28(7):1163–1171
Robinson D Jr, Esseltine DL, Regnault A, Meunier J, Liu K, van de Velde H (2016) The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials. Br J Haematol 174(3):368–381
Vogl DT, Delforge M, Song K, Guo S, Gibson CJ, Ervin-Haynes A, Facon T (2018) Long-term health-related quality of life in transplant-ineligible patients with newly diagnosed multiple myeloma receiving lenalidomide and dexamethasone. Leuk Lymphoma 59(2):398–405
Coleman EA, Goodwin JA, Coon SK, Richards K, Enderlin C, Kennedy R, Stewart CB, McNatt P, Lockhart K, Anaissie EJ, Barlogie B (2011) Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma. Cancer Nurs 34(3):219–227
Dimeo F, Schmittel A, Fietz T, Schwartz S, Kohler P, Boning D, Thiel E (2004) Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment. Ann Oncol 15(8):1237–1242
Franchignoni F, Horak F, Godi M, Nardone A, Giordano A (2010) Using psychometric techniques to improve the balance evaluation systems test: the mini-BESTest. J Rehabil Med 42(4):323–331
Rome SI, Jenkins BS, Lilleby KE (2011) Mobility and safety in the multiple myeloma survivor: survivorship care plan of the International Myeloma Foundation nurse leadership board. Clin J Oncol Nurs 15(4):41–52
Delforge M, Bladé J, Dimopoulos MA, Facon T, Kropff M, Ludwig H, Palumbo A, Van Damme P, San-Miguel JF, Sonneveld P (2010) Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues. Lancet Oncol 11(11):1086–1095
O’Hoski S, Winship B, Herridge L, Agha T, Brooks D, Beauchamp MK, Sibley KM (2014) Increasing the clinical utility of the BESTest, mini-BESTest, and brief-BESTest: normative values in Canadian adults who are healthy and aged 50 years or older. Phys Ther 94(3):334–342
Yun YH, Park YS, Lee ES, Bang S-M, Heo DS, Park S, You C, West K (2004) Validation of the Korean version of the EORTC QLQ-C30. Qual Life Res 13(4):863–868
Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A (2007) An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. Eur J Cancer 43(11):1670–1678
Fayers P, Bottomley A, Group EQoL (2002) Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer 38:125–133
Stone P, Richards M, A’hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11(5):561–567
Mystakidou K, Tsilika E, Parpa E, Smyrniotis V, Galanos A, Vlahos L (2007) Beck depression inventory: exploring its psychometric properties in a palliative care population of advanced cancer patients. Eur J Cancer Care 16(3):244–250
Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5(3):224–237
Black SA, Rush RD (2002) Cognitive and functional decline in adults aged 75 and older. J Am Geriatr Soc 50(12):1978–1986
Jørgensen TL, Hallas J, Friis S, Herrstedt J (2012) Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 106(7):1353–1360
Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78(1):21–33
Mittelman M (2003) The implications of anemia in multiple myeloma. Clin Lymphoma 4(Suppl 1):S23–S29
Bladé J, Rosiñol L (2005) Renal, hematologic and infectious complications in multiple myeloma. Best Pract Res Clin Haematol 18(4):635–652
Curt GA (2000) The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncol Suppl 2:9–12
Birgegård G, Gascón P, Ludwig H (2006) Evaluation of anaemia in patients with multiple myeloma and lymphoma: findings of the European CANCER ANAEMIA SURVEY. Eur J Haematol 77(5):378–386
Kim JE, Yoo C, Lee DH, Kim SW, Lee JS, Suh C (2010) Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma. Ann Hematol 89(4):391–397
Greipp PR, Miguel JS, Durie BG, Crowley JJ, Barlogie B, Bladé J, Boccadoro M, Child JA, Avet-Loiseau H, Kyle RA (2005) International staging system for multiple myeloma. J Clin Oncol 23(15):3412–3420
Sullivan DH (2001) Guest editorial: what do the serum proteins tell us about our elderly patients? J Gerontol A Biol Sci Med Sci 56(2):M71–M74
Rummans TA, Frost M, Suman VJ, Taylor M, Novotny P, Gendron T, Johnson R, Hartmann L, Dose AM, Evans RW (1998) Quality of life and pain in patients with recurrent breast and gynecologic cancer. Psychosomatics 39(5):437–445
Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E (1997) Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manag 13(2):63–74
Paice JA (2004) Assessment of symptom clusters in people with cancer. J Natl Cancer Inst Monogr 32:98–102
Gaston-Johansson F, Fall-Dickson JM, Bakos AB, Kennedy MJ (1999) Fatigue, pain, and depression in pre-autotransplant breast cancer patients. Cancer Pract 7(5):240–247
Alacacioglu A, Binicier O, Gungor O, Oztop I, Dirioz M, Yilmaz U (2010) Quality of life, anxiety, and depression in Turkish colorectal cancer patients. Support Care Cancer 18(4):417–421
Mohan A, Singh P, Singh S, Goyal A, Pathak A, Mohan C, Guleria R (2007) Quality of life in lung cancer patients: impact of baseline clinical profile and respiratory status. Eur J Cancer Care (Engl) 16(3):268–276
O'Brien BJ, Buxton MJ, Patterson DL (1993) Relationship between functional status and health-related quality-of-life after myocardial infarction. Med Care 31(10):950–955
Young-McCaughan S, Arzola SM (2007) Exercise intervention research for patients with cancer on treatment. Semin Oncol Nurs 23(4):264–274
Headley JA, Ownby KK, John LD (2004) The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum 31(5):977–983
Anderson KC, Kyle RA, Dalton WS, Landowski T, Shain K, Jove R, Hazlehurst L, Berenson J (2000) Multiple myeloma: new insights and therapeutic approaches. Hematol Am Soc Hematol Educ Program 2000(1):147–165
Rajkumar SV (2016) Multiple myeloma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91(7):719–734
Groeneveldt L, Mein G, Garrod R, Jewell AP, Van Someren K, Stephens R, D’Sa SP, Yong KL (2013) A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer 13. https://doi.org/10.1186/1471-2407-13-31
de Morton NA, Davidson M, Keating JL (2010) Validity, responsiveness and the minimal clinically important difference for the de Morton Mobility Index (DEMMI) in an older acute medical population. BMC Geriatr 10. https://doi.org/10.1186/1471-2318-10-72
MacKnight C, Rockwood K (2000) Rasch analysis of the hierarchical assessment of balance and mobility (HABAM). J Clin Epidemiol 53(12):1242–1247
Funding
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1A2B6001296).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kim, S.H., Kim, I., Koh, Y. et al. The importance of physical function in patients with multiple myeloma for improving quality of life. Support Care Cancer 28, 2361–2367 (2020). https://doi.org/10.1007/s00520-019-05054-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-019-05054-y